Industry and patient advocates also argue in favor of accelerated approval's ability to provide earlier access to drugs for diseases with unmet needs. • Source: Alamy
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
